Alyeska Investment Group
PRVA icon

Alyeska Investment Group’s Privia Health PRVA Stock Holding History

Alyeska Investment Group’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$767K Buy
+29,797
New +$690K ﹤0.01% 609
2025
Q1 		– Sell
-300,000
Closed -$5.87M – 633
2024
Q4 		$5.87M Buy
300,000
+50,000
+20% +$991K 0.02% 390
2024
Q3 		$4.55M Buy
+250,000
New +$4.77M 0.02% 365
2023
Q3 		– Sell
-812,312
Closed -$21.2M – 602
2023
Q2 		$21.2M Buy
812,312
+748,439
+1,172% +$19.8M 0.16% 180
2023
Q1 		$1.76M Sell
63,873
-837,752
-93% -$22.1M 0.02% 360
2022
Q4 		$20.5M Buy
901,625
+780,086
+642% +$21.7M 0.21% 146
2022
Q3 		$4.14M Sell
121,539
-230,606
-65% -$8.53M 0.05% 275
2022
Q2 		$10.3M Buy
+352,145
New +$8.95M 0.12% 206
2022
Q1 		– Sell
-200,000
Closed -$5.17M – 653
2021
Q4 		$5.17M Buy
+200,000
New +$4.99M 0.06% 272

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Alyeska Investment Group's PRVA Position: Q2 2026 in Review

Alyeska Investment Group opened a new position in Privia Health (PRVA) in Q2 2026: 29,797 shares worth $767K. The stake represents ﹤0.01% of the portfolio and ranks #609 among its holdings. This is a return to the name: Alyeska Investment Group previously reported a position in PRVA as recently as Q4 2024.

Alyeska Investment Group first reported a position in PRVA in Q4 2021 and has held it in 9 quarters since. The position peaked at $21.2M in Q2 2023. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Alyeska Investment Group held 29,797 shares of Privia Health worth $767K as of Q2 2026.
  • Privia Health was a new Alyeska Investment Group position in Q2 2026.
  • Privia Health made up ﹤0.01% of Alyeska Investment Group's portfolio in Q2 2026, its #609 holding.
  • Alyeska Investment Group first reported a position in Privia Health in Q4 2021 and has held it in 9 quarters since.
  • Alyeska Investment Group's Privia Health position peaked at $21.2M in Q2 2023.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.